Last Updated: November 8, 2026

Details for Patent: 6,372,760

Name: Drug Patent Intelligence for US Patent 6372760
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

« Back to Dashboard

Summary for Patent: 6,372,760

Title:	Stabilized composition comprising antidementia medicament
Abstract:	The present invention provides a stable composition of an antidementia medicament. Specifically, it is a stabilized composition of an antidementia medicament comprising an antidementia medicament and an organic acid. As the organic acid, tosyllic acid, mesyllic acid, benzoic acid, salicylic acid, tartaric acid, citric acid and the like are particularly preferable.
Inventor(s):	Akira Kato, Tsutomu Harada, Naokazu Murahashi, Yukiko Sugaya, Hidenobu Ando
Assignee:	Eisai Co Ltd
Application Number:	US09/700,342
Patent Claim Types: see list of patent claims	Use; Composition;

Drugs Protected by US Patent 6,372,760

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 6,372,760

PCT Information
PCT Filed	March 31, 1999	PCT Application Number:	PCT/JP99/01686
PCT Publication Date:	October 12, 2000	PCT Publication Number:	WO00/59544

International Family Members for US Patent 6,372,760

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	254928	⤷ Start Trial
Germany	69913138	⤷ Start Trial
Denmark	1086706	⤷ Start Trial
European Patent Office	1086706	⤷ Start Trial
Spain	2211056	⤷ Start Trial
Portugal	1086706	⤷ Start Trial
World Intellectual Property Organization (WIPO)	0059544	⤷ Start Trial
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.